Alprazolam

111,579 adverse event reports submitted to the FDA (2001–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Alprazolam in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Alprazolam adverse event reports by reporter sex
SexReports
Female67,062
Male36,671
Unknown481

By Age Group

View age group data as a table
Alprazolam adverse event reports by reporter age group
Age groupReports
0-171,857
18-3413,293
35-4917,490
50-6423,156
65-7413,735
75+11,223

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Alprazolam. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Alprazolam adverse event reports by reported outcome
OutcomeReports
Other Serious46,658
Hospitalization37,365
Death27,062
Non-Serious24,958
Life-Threatening5,305
Disability2,350

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Alprazolam. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Alprazolam adverse event reports by year
YearReports
20011
20031
20041,188
20051,449
20061,179
20071,007
20081,733
20091,855
20102,937
20113,327
20124,186
20134,593
20145,051
20156,462
20166,871
20177,354
20188,895
201910,294
20209,621
20217,108
20226,708
20236,202
20246,146
20255,971
2026 (partial)1,440

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Alprazolam

In FDA adverse event reports that mention Alprazolam, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026